Two-thirds of Americans approve of editing human DNA to treat disease
By Alessandra Potenza,
The Verge
| 08. 30. 2017
About two-thirds of Americans support the use of gene editing to treat diseases, according to a new survey. But opinions vary a lot based on people’s religious beliefs and how much they know about gene editing in general.
The research, published earlier this month in Science, shows that across the board, people want to be involved in a public discussion about editing the human genome. And that conversation with scientists and public officials needs to happen now, as the technology is still developing, says study co-author Dietram Scheufele, a science communication scholar at the University of Wisconsin-Madison. The results are based on a survey of 1,600 US adults conducted in December 2016 and January 2017.
The goal of the survey was to probe public opinion on a revolutionary piece of technology that’s advancing fast, Scheufele tells The Verge. The advent of powerful gene editing tools like CRISPR is making editing human DNA incredibly easy and precise. The technology holds the potential to rid humanity of diseaseslike sickle cell anemia. Earlier this month, researchers in the US...
Related Articles
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...
By Maia Hibbett, Wired | 09.09.2026
THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola player from Chongqing, China, a lover of science fiction, and an aspiring member of the US Army Reserve Officer Training...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Claire Robinson and Jonathan Matthews, Guest Contributors
| 08.25.2026
This is an excerpt of an article originally published on August 1, 2026 at GMWatch.
A six-year-old girl has died in a gene editing gene therapy trial in China that went wrong, the journal Science reports. Seven days after the girl's medical team infused trillions of viruses carrying the recipe for the gene editing tool – in this case a base editor – into her spinal fluid, she died of a severe immune reaction linked to the therapy.
Just...